Miriam Barry, Velindre University NHS Trust

Professor Roger Dale, Imperial College London

Roger Dale left the NHS in 2010 but continues to hold an academic position at Imperial College, London. His special interest for many years has been the development of unified radiobiological models which can be used to quantitatively assess many types of radiotherapy, e.g. biologically-targeted radionuclide therapy, high-LET therapy and all types of brachytherapy, as well as external beam therapy and chemoradiotherapy. Professor Dale has published extensively (often in collaboration with Professor Bleddyn Jones) and has  received several prestigious awards for his work.